4//SEC Filing
Dallas Matthew D 4
Accession 0001144204-19-029895
CIK 0001563665other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:32 PM ET
Size
8.1 KB
Accession
0001144204-19-029895
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Dallas Matthew D
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-03+10,364→ 10,364 totalExercise: $2.90Exp: 2029-06-03→ Common Stock, par value $0.01 per share (10,364 underlying) - Award
Stock Option (right to buy)
2019-06-03+8,411→ 18,775 totalExercise: $2.90Exp: 2029-06-03→ Common Stock, par value $0.01 per share (8,411 underlying)
Footnotes (2)
- [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 3, 2019, December 3, 2019, March 3, 2020, and June 3, 2020.
- [F2]This Stock Option was granted in lieu of 2019 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2019, September 30, 2019, and December 31, 2019.
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeother
Related Parties
1- filerCIK 0001612396
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:32 PM ET
- Size
- 8.1 KB